CIK 0000926617
- Non-accelerated filer
- Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330595156
- Phone
- +1 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 80 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-13 | Hombeck Torsten Chief Financial Officer | Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) | +22,000 | 22,000 | ||
| 2024-05-03 | Hombeck Torsten Chief Financial Officer | Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) | +6,667 | $3.20 | $21K | 6,667 |
| 2024-02-14 | Hombeck Torsten Chief Financial Officer | Grant or award · Employee stock option (right to buy) | +20,000 | 20,000 | ||
| 2023-11-17 | Hombeck Torsten Chief Financial Officer | Grant or award | +30,000 | 33,000 | ||
| 2023-09-08 | Hombeck Torsten Chief Financial Officer | Purchase | +2,246 | $4.30 | $10K | 3,000 |
| 2023-07-25 | Hombeck Torsten Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +13,334 | 13,334 | ||
| 2023-07-24 | Hombeck Torsten Chief Financial Officer | Purchase | +754 | $3.98 | $3K | 754 |
Page 1 of 1 · 7 trades